logo

Gamma Probe Device Market - Growth, Trends, COVID-19 Impact, and Forecasts (2021 - 2026)

The Gamma Probe Device Market is segmented by Modality Type (Standalone, and Mobile), Application (Parathyroid surgical treatment, and Sentinel lymph node mapping), and Geography

Home Industry Reports Healthcare Gamma Probe Device Market - Growth, Trends, COVID-19 Impact, and Forecasts (2021 ...

Market Snapshot

Gamma Probe Device Market
Study Period: 2018 - 2026
Base Year: 2020
Fastest Growing Market: Asia Pacific
Largest Market: North America
CAGR: 7.5 %

Need a report that reflects how COVID-19 has impacted this market and its growth?

Market Overview

The gamma probe device market is expected to register a CAGR of 7.5% during the forecast period. The market is growing at a good rate attributing to product launches with advanced features in gamma probe devices. For instance, in 2016, Dilon Technologies Inc. product Dilon Navigator 2.0, which is the latest generation of navigator system helps in for sentinel lymph node biopsy.

Moreover, the increasing incidences of breast cancer cases are also one of the major factors that are driving the overall market growth. For instance, according to the World Cancer Research Fund in 2018, there were around 2 million new cases of breast cancer that have promoted the surgical procedure wherein these devices are used for therapeutical and diagnosis purposes and further drives the growth for gamma probe devices.

Furthermore, radio-guided surgeries which involved gamma detection probe helps in minimizing the invasiveness of several diagnostic and therapeutic procedure with maximum benefits for cancer patients. However, the high cost of gamma probe devices may hamper the market.

Scope of the Report

A gamma probe is a device that contains a scintillation counter which measures and detects ionizing radiation for intraoperative use and these devices are also used for sentinel lymph node mapping, radioactive seed localization (RSL) to locate small and non-palpable breast lesions and parathyroid surgery. Gamma probe device market is segmented by modality type, application, and geography.

By Modality
Standalone
Mobile
By Application
Parathyroid Surgical Treatment
Sentinel Lymph Node Mapping
Other Applications
By End User
Hospitals
Ambulatory Surgical Centers
Other End Users
Geography
North America
United States
Canada
Mexico
Europe
Germany
United Kingdom
France
Italy
Spain
Rest of Europe
Asia-Pacific
China
Japan
India
Australia
South Korea
Rest of Asia-Pacific
Middle-East and Africa
GCC
South Africa
Rest of Middle-East and Africa
South America
Brazil
Argentina
Rest of South America

Report scope can be customized per your requirements. Click here.

Key Market Trends

Mobile Segment is Expected to Hold a Large Share of the Gamma Probe Device Market

  • Mobile devices are found to be highly preferred as these gamma probe devices give higher efficacy while maintaining a lower risk of damage. Moreover, continuous product development and innovation in gamma probe devices help in boosting the growth of the market. For instance, Bertin instruments have a product known as Gamma Tracer Spider, which is an ultra-compact self deployable with offering maximum protection.
  • Moreover, these mobile gamma probes are also used for parathyroid surgical treatment and sentinel lymph node mapping for diagnosing and thus propelling the market segment.
  • In addition, as per Globocan, in 2018, the number of cases of breast cancer worldwide results in promoting surgical procedures. The increasing number of surgical procedures promotes the high demand of gamma probe for diagnostic purposes and hence drive the overall market.
key trendsgamma123.png

North America is Expected to Hold a Significant Share in the Growth of the Gamma Probe Device Market

North America is expected to hold a significant market share in the gamma probe device market attributing to an increasing number of cancers affecting patients, increasing use of nuclear medicines and technological advancement with new product launches by major players in this region.

Moreover, high investments in R&D and government support regarding the use of medical isotopes in North America leading to an increase in demand for nucleic medicines and further contributes to the gamma probe market. Furthermore, increasing healthcare expenditure and the presence of well-established healthcare infrastructure is also fuelling the growth of the overall regional market to a large extent.

gamma probe geography.png

Competitive Landscape

Some of the companies which are currently dominating the market are Lake Shore Cryotronics Inc., Hologic Inc, Wake Medical, Raditec Medical AG, Thermo Fisher Scientific, Dilon Technologies Inc., Tron Medical Ltd, and Intramedica limaging.

COMPETITIVE.png

Table of Contents

  1. 1. INTRODUCTION

    1. 1.1 Study Assumptions

    2. 1.2 Scope of the Study

  2. 2. RESEARCH METHODOLOGY

  3. 3. EXECUTIVE SUMMARY

  4. 4. MARKET DYNAMICS

    1. 4.1 Market Overview

    2. 4.2 Market Drivers

      1. 4.2.1 Increasing Incidences of Breast Cancer

      2. 4.2.2 Rising Technological Advancement

    3. 4.3 Market Restraints

      1. 4.3.1 Cost Effective Alternatives

    4. 4.4 Porter's Five Force Analysis

      1. 4.4.1 Threat of New Entrants

      2. 4.4.2 Bargaining Power of Buyers/Consumers

      3. 4.4.3 Bargaining Power of Suppliers

      4. 4.4.4 Threat of Substitute Products

      5. 4.4.5 Intensity of Competitive Rivalry

  5. 5. MARKET SEGMENTATION

    1. 5.1 By Modality

      1. 5.1.1 Standalone

      2. 5.1.2 Mobile

    2. 5.2 By Application

      1. 5.2.1 Parathyroid Surgical Treatment

      2. 5.2.2 Sentinel Lymph Node Mapping

      3. 5.2.3 Other Applications

    3. 5.3 By End User

      1. 5.3.1 Hospitals

      2. 5.3.2 Ambulatory Surgical Centers

      3. 5.3.3 Other End Users

    4. 5.4 Geography

      1. 5.4.1 North America

        1. 5.4.1.1 United States

        2. 5.4.1.2 Canada

        3. 5.4.1.3 Mexico

      2. 5.4.2 Europe

        1. 5.4.2.1 Germany

        2. 5.4.2.2 United Kingdom

        3. 5.4.2.3 France

        4. 5.4.2.4 Italy

        5. 5.4.2.5 Spain

        6. 5.4.2.6 Rest of Europe

      3. 5.4.3 Asia-Pacific

        1. 5.4.3.1 China

        2. 5.4.3.2 Japan

        3. 5.4.3.3 India

        4. 5.4.3.4 Australia

        5. 5.4.3.5 South Korea

        6. 5.4.3.6 Rest of Asia-Pacific

      4. 5.4.4 Middle-East and Africa

        1. 5.4.4.1 GCC

        2. 5.4.4.2 South Africa

        3. 5.4.4.3 Rest of Middle-East and Africa

      5. 5.4.5 South America

        1. 5.4.5.1 Brazil

        2. 5.4.5.2 Argentina

        3. 5.4.5.3 Rest of South America

  6. 6. COMPETITIVE LANDSCAPE

    1. 6.1 Company Profiles

      1. 6.1.1 Lake Shore Cryotronics Inc.

      2. 6.1.2 Hologic Inc.

      3. 6.1.3 Wake Medical

      4. 6.1.4 Raditec Medical AG

      5. 6.1.5 Thermo Fisher Scientific

      6. 6.1.6 Dilon Technologies Inc.

      7. 6.1.7 Tron Medical Ltd

      8. 6.1.8 Intramedicalimaging

      9. 6.1.9 BERTIN INSTRUMENTS

      2. *List Not Exhaustive

  7. 7. MARKET OPPORTUNITIES AND FUTURE TRENDS

**Subject to Availability
**Competitive Landscape covers- Business Overview, Financials, Products and Strategies, and Recent Developments

You can also purchase parts of this report. Do you want to check out a section wise price list?

Frequently Asked Questions

The Gamma Probe Device Market market is studied from 2018 - 2026.

The Gamma Probe Device Market is growing at a CAGR of 7.5% over the next 5 years.

Asia Pacific is growing at the highest CAGR over 2021- 2026.

North America holds highest share in 2020.

Wake Medical, Raditec Medical AG, Thermo Fisher Scientific, Hologic, Inc, Dilon Technologies, Inc are the major companies operating in Gamma Probe Device Market.

80% of our clients seek made-to-order reports. How do you want us to tailor yours?

Please enter a valid email id!

Please enter a valid message!